Risk of Recurrence of Resected Stage I Non-small Cell Lung Cancer in Elderly Patients as Compared with Younger Patients

被引:57
|
作者
Goodgame, Boone [2 ]
Viswanathan, Avinash [2 ]
Zoole, Jennifer [3 ]
Gao, Feng [4 ]
Miller, C. Ryan [5 ,6 ]
Subramanian, Janakiraman [2 ]
Meyers, Bryan F. [3 ]
Patterson, Alexander G. [3 ]
Govindan, Ramaswamy [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Div Med Oncol, St Louis, MO 63110 USA
[2] Alvin J Siteman Canc Ctr, Div Med Oncol, St Louis, MO USA
[3] Alvin J Siteman Canc Ctr, Div Cardiothorac Surg, St Louis, MO USA
[4] Alvin J Siteman Canc Ctr, Div Biostat, St Louis, MO USA
[5] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA
[6] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
Elderly; Lung cancer; Surgery; Stage I; Outcomes; LONG-TERM SURVIVAL; PULMONARY RESECTION; SURGICAL RESECTION; EPIDEMIOLOGY; SURVEILLANCE; MODEL;
D O I
10.1097/JTO.0b013e3181b6bc1b
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Half of all patients with non-small cell lung cancer (NSCLC) are 70 years or older at the time of diagnosis. Surgery is an option for fit elderly patients with early stage disease, but rates of disease recurrence after surgical resection arc not well described. We report the outcomes in elderly patients (170 years or older) with stage I NSCLC after surgical resection. Patients and Methods: We conducted a retrospective study of patients diagnosed with stage I NSCLC after surgical resection at Washington University School of Medicine-Alvin J. Siteman Cancer Center from 1990 to 2000. Demographic, pathologic, treatment, and follow-up data were collected. Recurrence rates and overall survival were calculated by the Kaplan-Meier method. Multivariate Cox proportional hazards models were used to detect associations between potential prognostic factors and survival and recurrence. Results: Of the 715 patients with stage I NSCLC, 286 were 70 years or older at diagnosis. In this elderly cohort, the median age was 74 years (range, 70-89 years) and 140 of them were women (49%). Lobectomy was performed in 237 patients (83%) whereas 43 patients (15%) had a wedge or segmental resection, and six patients (2%) underwent pneumonectomy. Clinical and pathologic characteristics were not statistically different between the elderly and younger cohorts, with the exception that older patients were more likely to be white (90% versus 80%, p = 0.0003) and less likely to be smokers (88% versus 95%, p = 0.019) compared with the Younger cohort. With a median follow-up of 4.6 years, the overall 5-year survival rate was 52% with a 5-year recurrence rate of 24%. in comparison, the patients younger than 70 years had a 5-year survival rate of 67% (p < 0.001) and a 5-year recurrence rate of 24%. Conclusions: Although overall survival was worse in elderly patients, estimated disease recurrence rates after resection were identical.
引用
收藏
页码:1370 / 1374
页数:5
相关论文
共 50 条
  • [21] Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence
    Hung, J-J
    Hsu, W-H
    Hsieh, C-C
    Huang, B-S
    Huang, M-H
    Liu, J-S
    Wu, Y-C
    THORAX, 2009, 64 (03) : 192 - 196
  • [22] Prognosis of Patients with Stage I Non-Small Cell Lung Cancer
    Flores, C. J.
    Chirinos, L.
    Enriquez, D.
    Schwarz, L. J.
    Mas, L.
    Rojas, V.
    Aguilar, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1185 - S1185
  • [23] Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer
    Mizuguchi, Shinjiro
    Izumi, Nobuhiro
    Tsukioka, Takuma
    Komatsu, Hiroaki
    Nishiyama, Noritoshi
    JOURNAL OF CARDIOTHORACIC SURGERY, 2018, 13
  • [24] Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer
    Shinjiro Mizuguchi
    Nobuhiro Izumi
    Takuma Tsukioka
    Hiroaki Komatsu
    Noritoshi Nishiyama
    Journal of Cardiothoracic Surgery, 13
  • [25] Dynamics of Brain Metastasis for Curatively Resected Stage I or II Non-Small Cell Lung Cancer Patients
    Shin, Sumin
    Park, Byung Jo
    Cho, Jong Ho
    Kim, Hong Kwan
    Choi, Yong Soo
    Zo, Jae Ill
    Shim, Young Mog
    Kim, Jhingook
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S639 - S639
  • [26] A Retrospective Study of Oligo-Recurrence in Patients with Resected Non-Small Cell Lung Cancer
    Nakagawa, T.
    Kudo, S.
    Takashima, S.
    Iwai, H.
    Suzuki, H.
    Minamiya, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S943 - S943
  • [27] Is there a benefit of TKIs among the elderly compared with younger patients in non-small cell lung cancer? a meta-analysis.
    Landre, Thierry
    Nicolas, Patrick
    Uzzan, Bernard
    Chouahnia, Kader
    Taleb, Cherifa
    Boudabous, Hanene
    Zelek, Laurent H.
    Des Guetz, Gaetan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Prognostic Factors for Post Recurrence Survival in Resected Pathological Stage I Non-small Cell Lung Cancer
    Kubouchi, Yasuaki
    Kidokoro, Yoshiteru
    Ohno, Takashi
    Yurugi, Yohei
    Wakahara, Makoto
    Haruki, Tomohiro
    Nakamura, Hiroshige
    YONAGO ACTA MEDICA, 2017, 60 (04) : 213 - 219
  • [29] Prognostic Factors of Post-Recurrence Survival in Resected Stage I Non-Small Cell Lung Cancer
    Kubouchi, Yasuaki
    Kidokoro, Yoshiteru
    Oono, Takashi
    Yurugi, Yohei
    Wakahara, Makoto
    Miwa, Ken
    Araki, Kunio
    Taniguchi, Yuji
    Nakamura, Hiroshige
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S650 - S650
  • [30] ASSESSING THE UTILIZATION OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A511 - A511